Replies to post #227743 on Biotech Values

[DewDiligence]

(Quiz)—Activist shareholder blasts ONVO reverse-merger:

https://www.sec.gov/Archives/edgar/data/1497253/000149315220003257/formpx14a6g.htm

Quiz: There’s a half-truth in this letter that relates to Taylor Crouch’s tenure as CEO of Variagenics, which reverse-merged with Hyseq in 2003 to form Nuvelo; what is the half-truth?

[DewDiligence]

ONVO shareholder vote on revere-merger with Tarveda delayed until 4/7/20 due to inadequate support for merger proposal:

https://www.sec.gov/Archives/edgar/data/1497253/000156459020013657/onvo-ex991_6.htm

The recent SEC filing by the activist shareholder opposed to the merger (#msg-154143038) undoubtedly played a role in blocking a positive vote—at least for now.